Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DM6ENSJ)

Drug Name	Tralokinumab DM6ENSJ
Synonyms	CAT-354; Anti-IL 13 monoclonal antibody, CAT/AstraZeneca; IL-13 antagonist, CAT/AstraZeneca; Interleukin-13 antagonist, CAT/AstraZeneca
Drug Type	Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Atopic dermatitis	DISTCP41	EA80	Approved	[1]
------------------------------------------------------------------------------------

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Ulcerative colitis	DIS8K27O	DD71	Phase 3	[2]
------------------------------------------------------------------------------------

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Asthma	DISW9QNS	CA23	Phase 1/2	[3]
------------------------------------------------------------------------------------

References

1	FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761180.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8001).
3	ClinicalTrials.gov (NCT02085473) A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Tralokinumab When Delivered at Different Flow Rates to Healthy Volunteers